NOT FOR DISTRIBUTION
Header cover image

Market Cap

CA$27.3m

Last Updated

2021/05/09 22:40 UTC

Data Sources

Company Financials +

Executive Summary

MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. More Details


Snowflake Analysis

Limited growth with imperfect balance sheet.


Similar Companies

Share Price & News

How has MedX Health's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: MDX is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 15% a week.

Volatility Over Time: MDX's weekly volatility (15%) has been stable over the past year.


Market Performance


7 Day Return

-6.1%

MDX

2.4%

CA Medical Equipment

2.3%

CA Market


1 Year Return

10.7%

MDX

32.5%

CA Medical Equipment

36.9%

CA Market

Return vs Industry: MDX underperformed the Canadian Medical Equipment industry which returned 32.5% over the past year.

Return vs Market: MDX underperformed the Canadian Market which returned 36.9% over the past year.


Shareholder returns

MDXIndustryMarket
7 Day-6.1%2.4%2.3%
30 Day-16.2%-7.4%2.1%
90 Day19.2%-19.9%7.5%
1 Year10.7%10.7%32.5%32.5%41.4%36.9%
3 Year-22.5%-22.5%-63.8%-63.8%30.2%17.7%
5 Year138.5%138.5%86.8%86.8%60.3%36.3%

Long-Term Price Volatility Vs. Market

How volatile is MedX Health's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is MedX Health undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether MedX Health is trading at an attractive price based on the cash flow it is expected to produce in the future. But as MedX Health has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Future Growth

How is MedX Health forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

94.5%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if MDX's forecast earnings growth is above the savings rate (1.5%).

Earnings vs Market: Insufficient data to determine if MDX's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: MDX's revenue (94.5% per year) is forecast to grow faster than the Canadian market (6.8% per year).

High Growth Revenue: MDX's revenue (94.5% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if MDX's Return on Equity is forecast to be high in 3 years time


Past Performance

How has MedX Health performed over the past 5 years?

-27.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MDX is currently unprofitable.

Growing Profit Margin: MDX is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: MDX is unprofitable, and losses have increased over the past 5 years at a rate of 27.7% per year.

Accelerating Growth: Unable to compare MDX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MDX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (21.2%).


Return on Equity

High ROE: MDX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Financial Health

How is MedX Health's financial position?


Financial Position Analysis

Short Term Liabilities: MDX has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: MDX has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: MDX has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: MDX's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MDX has sufficient cash runway for 0 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: MDX is forecast to have sufficient cash runway for 0 months based on free cash flow estimates, but has since raised additional capital.


Dividend

What is MedX Health current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate MDX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MDX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MDX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MDX's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MDX's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.4yrs

Average management tenure


CEO

Rob von der Porten

0.83

Tenure

CA$112,500

Compensation

Mr. Robert von der Porten, also known as Rob, MBA, BA, has been Chairman of the Board of MedX Health Corp. from September 18, 2018 and serves as its Director since November 29, 2013. Mr. von der Porten ser...


CEO Compensation Analysis

Compensation vs Market: Insufficient data to establish whether Rob's total compensation is reasonable compared to companies of similar size in the Canadian market.

Compensation vs Earnings: Rob's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: MDX's management team is considered experienced (4.4 years average tenure).


Board Members

Experienced Board: MDX's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.8%.


Top Shareholders

Company Information

MedX Health Corp's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: MedX Health Corp
  • Ticker: MDX
  • Exchange: TSXV
  • Founded: 1999
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: CA$27.274m
  • Shares outstanding: 175.96m
  • Website: https://www.medxhealth.com

Location

  • MedX Health Corp
  • 1495 Bonhill Road
  • Unit #1
  • Mississauga
  • Ontario
  • L5T 1M2
  • Canada

Listings


Biography

MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United S...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/09 22:40
End of Day Share Price2021/05/07 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.